Metabolic Syndrome (MetS) is a complex disorder that involves a cluster of metabolic abnormalities, including central obesity, insulin resistance, dyslipidemia, and hypertension. It is a significant public health problem and a leading cause of cardiovascular disease and type 2 diabetes mellitus. The molecular mechanisms underlying the development of MetS are multifactorial and involve a combination of genetic, environmental, and lifestyle factors. In this review, we discuss the molecular mechanisms of MetS and potential therapeutic targets.
HTML PDFShare this article
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report
